MYC and cancer: The mTORC2 is reported as a critical regulator of cancer cell metabolism through two mechanisms: Akt-dependent and Akt-independent signaling, leads to the acetylation of FoxO1 and FoxO3, causing release of c-Myc from a suppressive microRNA network63.